Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of botulinum toxin type A in patellofemoral pain syndrome
IRCT20221202056684N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in patellofemoral pain syndrome (PFPS), sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
patellofemoral pain syndrome (PFPS)
Beyond the preview
Go deeper on IRCT20221202056684N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221202056684N1.